Guardian Pharmacy Services Stock Price Patterns
| GRDN Stock | 33.04 0.21 0.64% |
Momentum 55
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter 0.25 | EPS Estimate Current Year 0.9825 | EPS Estimate Next Year 1.125 | Wall Street Target Price 35 | EPS Estimate Current Quarter 0.235 |
Using Guardian Pharmacy hype-based prediction, you can estimate the value of Guardian Pharmacy Services from the perspective of Guardian Pharmacy response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Guardian Pharmacy using Guardian Pharmacy's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Guardian using crowd psychology based on the activity and movement of Guardian Pharmacy's stock price.
Guardian Pharmacy Implied Volatility | 0.88 |
Guardian Pharmacy's implied volatility exposes the market's sentiment of Guardian Pharmacy Services stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Guardian Pharmacy's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Guardian Pharmacy stock will not fluctuate a lot when Guardian Pharmacy's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Guardian Pharmacy to buy its stock at a price that has no basis in reality. In that case, they are not buying Guardian because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Guardian Pharmacy after-hype prediction price | USD 32.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Guardian contract
Based on the Rule 16, the options market is currently suggesting that Guardian Pharmacy Services will have an average daily up or down price movement of about 0.055% per day over the life of the 2026-04-17 option contract. With Guardian Pharmacy trading at USD 33.04, that is roughly USD 0.0182 . If you think that the market is fully incorporating Guardian Pharmacy's daily price movement you should consider acquiring Guardian Pharmacy Services options at the current volatility level of 0.88%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Guardian Pharmacy Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardian Pharmacy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardian Pharmacy After-Hype Price Density Analysis
As far as predicting the price of Guardian Pharmacy at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Guardian Pharmacy or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Guardian Pharmacy, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Guardian Pharmacy Estimiated After-Hype Price Volatility
In the context of predicting Guardian Pharmacy's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Guardian Pharmacy's historical news coverage. Guardian Pharmacy's after-hype downside and upside margins for the prediction period are 29.51 and 34.79, respectively. We have considered Guardian Pharmacy's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Guardian Pharmacy is very steady at this time. Analysis and calculation of next after-hype price of Guardian Pharmacy is based on 3 months time horizon.
Guardian Pharmacy Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Guardian Pharmacy is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Guardian Pharmacy backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Guardian Pharmacy, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 2.62 | 0.70 | 0.12 | 11 Events / Month | 7 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
33.04 | 32.15 | 2.07 |
|
Guardian Pharmacy Hype Timeline
Guardian Pharmacy is currently traded for 33.04. The entity has historical hype elasticity of -0.7, and average elasticity to hype of competition of 0.12. Guardian is forecasted to decline in value after the next headline, with the price expected to drop to 32.15. The average volatility of media hype impact on the company price is about 108.26%. The price decrease on the next news is expected to be -2.07%, whereas the daily expected return is currently at 0.29%. The volatility of related hype on Guardian Pharmacy is about 637.47%, with the expected price after the next announcement by competition of 33.16. About 38.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days. Check out Guardian Pharmacy Basic Forecasting Models to cross-verify your projections.Guardian Pharmacy Related Hype Analysis
Having access to credible news sources related to Guardian Pharmacy's direct competition is more important than ever and may enhance your ability to predict Guardian Pharmacy's future price movements. Getting to know how Guardian Pharmacy's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Guardian Pharmacy may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TXG | 10X Genomics | (0.97) | 9 per month | 3.17 | 0.07 | 7.46 | (5.65) | 19.99 | |
| PRCT | Procept Biorobotics Corp | 0.57 | 5 per month | 0.00 | (0.04) | 7.06 | (5.10) | 17.65 | |
| TWST | Twist Bioscience Corp | 1.23 | 12 per month | 2.88 | 0.21 | 7.70 | (4.95) | 17.96 | |
| NUVB | Nuvation Bio | (0.09) | 9 per month | 4.41 | 0.06 | 6.34 | (5.41) | 68.61 | |
| NHC | National HealthCare | (1.55) | 6 per month | 1.52 | 0.17 | 4.32 | (2.46) | 9.28 | |
| QDEL | Quidel | 0.40 | 6 per month | 4.46 | 0.03 | 5.87 | (6.16) | 31.84 | |
| MD | Mednax Inc | 0.34 | 5 per month | 0.00 | (0.04) | 2.95 | (3.57) | 7.73 | |
| MESO | Mesoblast | 0.68 | 9 per month | 3.44 | 0.04 | 7.21 | (4.97) | 19.08 | |
| JANX | Janux Therapeutics | 1.35 | 10 per month | 0.00 | (0.11) | 7.88 | (5.07) | 63.52 | |
| EWTX | Edgewise Therapeutics | 2.15 | 10 per month | 4.34 | 0.11 | 11.41 | (5.57) | 38.85 |
Guardian Pharmacy Additional Predictive Modules
Most predictive techniques to examine Guardian price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Guardian using various technical indicators. When you analyze Guardian charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Guardian Pharmacy Predictive Indicators
The successful prediction of Guardian Pharmacy stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Guardian Pharmacy Services, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Guardian Pharmacy based on analysis of Guardian Pharmacy hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Guardian Pharmacy's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Guardian Pharmacy's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0395 | 0.0285 | 0.0256 | 0.022 | Price To Sales Ratio | 0.93 | 1.02 | 1.18 | 1.35 |
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving together with Guardian Stock
Moving against Guardian Stock
| 0.69 | 3GX | HF FOODS GRP | PairCorr |
| 0.46 | HITI | High Tide | PairCorr |
| 0.4 | MRU | Metro Inc | PairCorr |
| 0.38 | DTCK | Davis Commodities | PairCorr |
| 0.34 | GO | Grocery Outlet Holding | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Guardian Pharmacy Basic Forecasting Models to cross-verify your projections. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets | Return On Equity |
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.